Tech Company Financing Transactions

Allena Pharmaceuticals Funding Round

Bessemer Venture Partners, Frazier Healthcare Partners and Third Rock Ventures participated in a $15 million Series A capital raise for Allena Pharmaceuticals. This venture round was recorded on 11/17/2011.

Transaction Overview

Company Name
Allena Pharmaceuticals
Announced On
11/17/2011
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors

Bessemer Venture Partners (Lead Investor) (Stephen Kraus)

Frazier Healthcare Partners (Lead Investor) (James Topper)

Third Rock Ventures (Lead Investor) (Robert Tepper)

Proceeds Purpose
Proceeds from the financing will be used to accelerate the development of Allena's non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Executive Park Dr. 202
Newton, MA 02462
USA
Phone
617-467-4577
Website
www.allenapharma.com
Email Address
[email protected]
Overview
Allena Pharmaceuticals (Nasdaq: ALNA) develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Profile
Allena Pharmaceuticals LinkedIn Company Profile
Social Media
Allena Pharmaceuticals Company Twitter Account
Company News
Allena Pharmaceuticals News
Facebook
Allena Pharmaceuticals on Facebook
YouTube
Allena Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Louis Brenner
  Louis Brenner LinkedIn Profile  Louis Brenner Twitter Account  Louis Brenner News  Louis Brenner on Facebook
Chief Financial Officer
Edward Wholihan
  Edward Wholihan LinkedIn Profile  Edward Wholihan Twitter Account  Edward Wholihan News  Edward Wholihan on Facebook
Chief Medical Officer
Annamaria Kausz
  Annamaria Kausz LinkedIn Profile  Annamaria Kausz Twitter Account  Annamaria Kausz News  Annamaria Kausz on Facebook
Vice President
Geoffrey Swire
  Geoffrey Swire LinkedIn Profile  Geoffrey Swire Twitter Account  Geoffrey Swire News  Geoffrey Swire on Facebook
VP - Operations
Hugh Wight
  Hugh Wight LinkedIn Profile  Hugh Wight Twitter Account  Hugh Wight News  Hugh Wight on Facebook
VP - Regulatory Affairs
Stephen Yu
  Stephen Yu LinkedIn Profile  Stephen Yu Twitter Account  Stephen Yu News  Stephen Yu on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/17/2011: Medivo venture capital transaction
Next: 11/17/2011: Spotzot venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.